01
90% of subjects tolerated escalation
to 6 mg four times a day (maximum dose).
02
No Serious Adverse Effects (SAEs) during NP002 dose escalation or at maintenance dose.
03
No nicotine withdrawal symptoms based on MNWS-R (Minnesota Withdrawal Scale-Revised) scale.
04
No impulsivity signal based on JayMIDI (Jay Modified Minnesota Impulsive Disorders Interview).